Running Point Capital Advisors, LLC Johnson & Johnson Transaction History

Running Point Capital Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$154.35 - $166.11 $1,234 - $1,328	-8 Reduced 0.49%	1,625 $268,000
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $8,458 - $10,094	-56 Reduced 3.32%	1,633 $253,000
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $17,141 - $19,237	107 Added 6.76%	1,689 $298,000
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $26,458 - $29,441	164 Added 11.57%	1,582 $258,000
Q2 2022 Aug 02, 2022	SELL	$168.19 - $186.01 $23,714 - $26,227	-141 Reduced 9.04%	1,418 $252,000
Q1 2022 May 12, 2022	BUY	$158.14 - $179.59 $32,576 - $36,995	206 Added 15.23%	1,559 $276,000
Q4 2021 Feb 10, 2022	SELL	$155.93 - $173.01 $33,992 - $37,716	-218 Reduced 13.88%	1,353 $231,000
Q3 2021 Nov 15, 2021	BUY	$161.5 - $179.47 $23,902 - $26,561	148 Added 10.4%	1,571 $254,000
Q2 2021 Aug 12, 2021	BUY	$159.48 - $171.07 $226,940 - $243,432	1,423 New	1,423 $234,000

4,239

1.7B

12.5M

10.3M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Running Point Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Running Point Capital Advisors, LLC with notifications on news.